Jamil Khurram bought GALT
January 2, 2026 · Form 4 insider transaction
Jamil Khurram bought 60,000 shares of Galectin Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderJamil Khurram
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock acquired for no additional consideration resulting from vesting of Restricted Stock Units.